Works by Kieburtz, Karl

Results: 125
    1

    Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials Initiative.

    Published in:
    Journal of Parkinson's Disease, 2024, v. 14, n. 4, p. 657, doi. 10.3233/JPD-230363
    By:
    • Wyse, Richard K.;
    • Isaacs, Tom;
    • Barker, Roger A.;
    • Cookson, Mark R.;
    • Dawson, Ted M.;
    • Devos, David;
    • Dexter, David T.;
    • Duffen, Joy;
    • Federoff, Howard;
    • Fiske, Brian;
    • Foltynie, Thomas;
    • Fox, Susan;
    • Greenamyre, J. Timothy;
    • Kieburtz, Karl;
    • Kordower, Jeffrey H.;
    • Krainc, Dimitri;
    • Matthews, Helen;
    • Moore, Darren J.;
    • Mursaleen, Leah;
    • Schwarzschild, Michael A.
    Publication type:
    Article
    2

    Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease Progression.

    Published in:
    Journal of Parkinson's Disease, 2023, v. 13, n. 6, p. 899, doi. 10.3233/JPD-223433
    By:
    • Brumm, Michael C.;
    • Siderowf, Andrew;
    • Simuni, Tanya;
    • Burghardt, Elliot;
    • Choi, Seung Ho;
    • Caspell-Garcia, Chelsea;
    • Chahine, Lana M.;
    • Mollenhauer, Brit;
    • Foroud, Tatiana;
    • Galasko, Douglas;
    • Merchant, Kalpana;
    • Arnedo, Vanessa;
    • Hutten, Samantha J.;
    • O'Grady, Alyssa N.;
    • Poston, Kathleen L.;
    • Tanner, Caroline M.;
    • Weintraub, Daniel;
    • Kieburtz, Karl;
    • Marek, Kenneth;
    • Coffey, Christopher S.
    Publication type:
    Article
    3

    Trichloroethylene: An Invisible Cause of Parkinson's Disease?

    Published in:
    Journal of Parkinson's Disease, 2023, v. 13, n. 2, p. 203, doi. 10.3233/JPD-225047
    By:
    • Dorsey, E. Ray;
    • Zafar, Maryam;
    • Lettenberger, Samantha E.;
    • Pawlik, Meghan E.;
    • Kinel, Dan;
    • Frissen, Myrthe;
    • Schneider, Ruth B.;
    • Kieburtz, Karl;
    • Tanner, Caroline M.;
    • De Miranda, Briana R.;
    • Goldman, Samuel M.;
    • Bloem, Bastiaan R.
    Publication type:
    Article
    4

    Deep Phenotyping of Parkinson's Disease.

    Published in:
    Journal of Parkinson's Disease, 2020, v. 10, n. 3, p. 855, doi. 10.3233/JPD-202006
    By:
    • Dorsey, E. Ray;
    • Omberg, Larsson;
    • Waddell, Emma;
    • Adams, Jamie L.;
    • Adams, Roy;
    • Ali, Mohammad Rafayet;
    • Amodeo, Katherine;
    • Arky, Abigail;
    • Augustine, Erika F.;
    • Dinesh, Karthik;
    • Hoque, Mohammed Ehsan;
    • Glidden, Alistair M.;
    • Jensen-Roberts, Stella;
    • Kabelac, Zachary;
    • Katabi, Dina;
    • Kieburtz, Karl;
    • Kinel, Daniel R.;
    • Little, Max A.;
    • Lizarraga, Karlo J.;
    • Myers, Taylor
    Publication type:
    Article
    5

    GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop.

    Published in:
    Journal of Parkinson's Disease, 2020, v. 10, n. 3, p. 875, doi. 10.3233/JPD-202004
    By:
    • Barker, Roger A.;
    • Björklund, Anders;
    • Gash, Don M.;
    • Whone, Alan;
    • Van Laar, Amber;
    • Kordower, Jeffrey H.;
    • Bankiewicz, Krystof;
    • Kieburtz, Karl;
    • Saarma, Mart;
    • Booms, Sigrid;
    • Huttunen, Henri J.;
    • Kells, Adrian P.;
    • Fiandaca, Massimo S.;
    • Stoessl, A. Jon;
    • Eidelberg, David;
    • Federoff, Howard;
    • Voutilainen, Merja H.;
    • Dexter, David T.;
    • Eberling, Jamie;
    • Brundin, Patrik
    Publication type:
    Article
    6
    7

    Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change Measures.

    Published in:
    Journal of Parkinson's Disease, 2019, v. 9, n. 4, p. 665, doi. 10.3233/JPD-181518
    By:
    • Chahine, Lana M.;
    • Siderowf, Andrew;
    • Barnes, Janel;
    • Seedorff, Nicholas;
    • Caspell-Garcia, Chelsea;
    • Simuni, Tanya;
    • Coffey, Christopher S.;
    • Galasko, Douglas;
    • Mollenhauer, Brit;
    • Arnedo, Vanessa;
    • Daegele, Nichole;
    • Frasier, Mark;
    • Tanner, Caroline;
    • Kieburtz, Karl;
    • Marek, Kenneth
    Publication type:
    Article
    8
    9
    10

    Dopamine transporter imaging predicts clinically‐defined α‐synucleinopathy in REM sleep behavior disorder.

    Published in:
    Annals of Clinical & Translational Neurology, 2021, v. 8, n. 1, p. 201, doi. 10.1002/acn3.51269
    By:
    • Chahine, Lana M.;
    • Brumm, Michael C.;
    • Caspell‐Garcia, Chelsea;
    • Oertel, Wolfgang;
    • Mollenhauer, Brit;
    • Amara, Amy;
    • Fernandez‐Arcos, Ana;
    • Tolosa, Eduardo;
    • Simonet, Cristina;
    • Hogl, Birgit;
    • Videnovic, Aleksandar;
    • Hutten, Samantha J.;
    • Tanner, Caroline;
    • Weintraub, Daniel;
    • Burghardt, Elliot;
    • Coffey, Christopher;
    • Cho, Hyunkeun R.;
    • Kieburtz, Karl;
    • Poston, Kathleen L.;
    • Merchant, Kalpana
    Publication type:
    Article
    11

    The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort.

    Published in:
    Annals of Clinical & Translational Neurology, 2018, v. 5, n. 12, p. 1460, doi. 10.1002/acn3.644
    By:
    • Marek, Kenneth;
    • Chowdhury, Sohini;
    • Siderowf, Andrew;
    • Lasch, Shirley;
    • Coffey, Christopher S.;
    • Caspell‐Garcia, Chelsea;
    • Simuni, Tanya;
    • Jennings, Danna;
    • Tanner, Caroline M.;
    • Trojanowski, John Q.;
    • Shaw, Leslie M.;
    • Seibyl, John;
    • Schuff, Norbert;
    • Singleton, Andrew;
    • Kieburtz, Karl;
    • Toga, Arthur W.;
    • Mollenhauer, Brit;
    • Galasko, Doug;
    • Chahine, Lana M.;
    • Weintraub, Daniel
    Publication type:
    Article
    12
    13
    14
    15
    16

    Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau<sub>181</sub>, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease.

    Published in:
    JAMA Neurology, 2013, v. 70, n. 10, p. 1277, doi. 10.1001/jamaneurol.2013.3861
    By:
    • Ju-Hee Kang;
    • Irwin, David J.;
    • Chen-Plotkin, Alice S.;
    • Siderowf, Andrew;
    • Caspell, Chelsea;
    • Coffey, Christopher S.;
    • Waligórska, Teresa;
    • Taylor, Peggy;
    • Pan, Sarah;
    • Frasier, Mark;
    • Marek, Kenneth;
    • Kieburtz, Karl;
    • Jennings, Danna;
    • Simuni, Tanya;
    • Tanner, Caroline M.;
    • Singleton, Andrew;
    • Toga, Arthur W.;
    • Chowdhury, Sohini;
    • Mollenhauer, Brit;
    • Trojanowski, John Q.
    Publication type:
    Article
    17
    18
    19
    20

    Moving Parkinson care to the home.

    Published in:
    2016
    By:
    • Dorsey, E. Ray;
    • Vlaanderen, Floris P.;
    • Engelen, Lucien JLPG;
    • Kieburtz, Karl;
    • Zhu, William;
    • Biglan, Kevin M.;
    • Faber, Marjan J.;
    • Bloem, Bastiaan R.
    Publication type:
    journal article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Ethics of sham surgery: Perspective of patients.

    Published in:
    Movement Disorders, 2008, v. 23, n. 1, p. 63, doi. 10.1002/mds.21775
    By:
    • Frank, Samuel A.;
    • Wilson, Renee;
    • Holloway, Robert G.;
    • Zimmerman, Carol;
    • Peterson, Derick R.;
    • Kieburtz, Karl;
    • Kim, Scott Y.H.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49

    A controlled trial of remacemide hydrochloride in Huntington's disease.

    Published in:
    Movement Disorders, 1996, v. 11, n. 3, p. 273, doi. 10.1002/mds.870110310
    By:
    • Kieburtz, Karl;
    • Feigin, Andrew;
    • McDermott, Michael;
    • Como, Peter;
    • Abwender, David;
    • Zimmerman, Carol;
    • Hickey, Charlyne;
    • Orme, Constance;
    • Claude, Kathy;
    • Sotack, Jennie;
    • Greenamyre, J. Timothy;
    • Dunn, Cynthia;
    • Shoulson, Ira
    Publication type:
    Article
    50